Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EktaH is a French biotechnology company specializing in the discovery and development of innovative taste modulators to address global health challenges like obesity and diabetes. Utilizing a proprietary cell-based screening platform that mimics human taste receptors, the company identifies compounds that enhance the perception of sweetness, saltiness, and fat. This technology enables food manufacturers to significantly reduce sugar, salt, and lipid content without compromising sensory appeal. EktaH's approach bridges the gap between biotechnology and nutrition, focusing on metabolic health through sensory science. The company was founded as a spin-off from the Centre des Sciences du Goût et de l'Alimentation (CSGA) in Dijon.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EktaH.